Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 199.05
-0.45 (-0.23%)
At close: Jan 8, 2026
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 15.58 billion as of January 8, 2026. Its market cap has increased by 0.76% in one year.
Market Cap
15.58B
Enterprise Value
12.74B
Revenue
6.89B
Ranking
n/a
PE Ratio
6.46
Stock Price
199.05
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 15.58B, an increase of 36,375.74%. That is a compound annual growth rate of 24.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 15.61B | 4.53% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.62T |
| Genmab | 130.34B |
| Coloplast | 126.66B |
| ALK-Abelló | 49.94B |
| Demant | 47.67B |
| H. Lundbeck | 41.51B |
| Zealand Pharma | 30.41B |
| Ambu A/S | 24.02B |